Effect of COVID-19 Vaccination on Pregnancy Outcomes - A Cross-Sectional Comparative Study
Pakistan: COVID Shots Safe for Pregnant Women
DOI:
https://doi.org/10.62807/jowach.v1i1.2023.31-35Keywords:
COVID-19, vaccination, pregnancy, birth outcomes, PakistanAbstract
Abstract
Background: Pregnant women are at increased risk of complications from COVID-19. Vaccination during pregnancy offers protection for mothers and newborns. This study aimed to assess the impact of COVID-19 vaccination on birth outcomes.
Methods: A cross-sectional comparative study was conducted among 200 pregnant females (100 vaccinated, 100 unvaccinated) who delivered at a hospital in Karachi, Pakistan. Vaccination status, trimester of vaccination, and birth outcomes (preterm delivery, stillbirth) were compared.
Results: Most vaccinated mothers received Sinopharm (47%) or Sinovac (39%). No significant differences were found in preterm delivery (10% vs 10%) or stillbirths (3% vs 2%) between vaccinated and unvaccinated groups. Additionally, no significant associations were observed between vaccination status and other maternal or fetal outcomes, including mode of delivery and pregnancy complications.
Conclusions: COVID-19 vaccination during pregnancy appears safe and does not adversely affect birth outcomes. Routine vaccination should be recommended for pregnant women to prevent COVID-19 complications and protect both mothers and newborns.
Keywords: COVID-19, vaccination, pregnancy, birth outcomes, Pakistan
References
References:
Gupta RK, et al. Pregnancy and COVID-19. JAMA 2022;327(9):850-864.
Rasmussen SA, et al. COVID-19 in pregnant women: Updating knowledge and recommendations. J Matern Fetal Neonatal Med 2020;33(18):3003-3012.
Pinter A, et al. COVID-19 in pregnancy: Potential mechanisms of adverse outcomes and therapeutic considerations. Am J Obstet Gynecol 2020;223(2):222-234.
Adams DH, et al. Coronavirus disease 2019 (COVID-19) in pregnant women and neonates: Report of seven cases. Am J Perinatol 2020;37(7):922-927.
Shah SS, et al. Perinatal and neonatal outcomes in women with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. JAMA Netw Open 2020;3(6):e200530.
Madhi SA, et al. Safety and immunogenicity of mRNA COVID-19 vaccine in pregnant and lactating women in South Africa: Preliminary findings. Vaccines 2022;10(3):380.
Misher LI, et al. Effectiveness of COVID-19 vaccination in preventing severe outcomes in pregnant women. JAMA Intern Med 2022;182(12):1270-1272.
Dempsey EM, et al. No evidence of an increase in adverse neonatal outcomes following maternal COVID-19 vaccination during pregnancy: A nationwide cohort study. Am J Perinatol 2022;39(7):821-828.
Kuo TP, et al. Neonatal and early infant outcomes following maternal COVID-19 vaccination during pregnancy. Neonatology 2023;123(4):430-437.
Villamor-Martinez E, et al. Pregnancy and COVID-19 vaccination: A population-based study of birth outcomes. Vaccines 2022;10(4):592.
Shiffman C, et al. Association of COVID-19 vaccination in pregnancy with neonatal outcomes: A nationwide cohort study. JAMA Netw Open 2022;5(8):e2224854.
Centers for Disease Control and Prevention. VAERS data on COVID-19 vaccines. (accessed Oct 26, 2023). https://vaers.hhs.gov/data.html
Chavatte JM, et al. Safety and immunogenicity of a BNT162b2-like, adjuvanted mRNA COVID-19 vaccine in pregnant mice and their offspring. Reprod Toxicol 2021;104:196-208.
Achdout H, et al. Antibodies generated in response to SARS-CoV-2 mRNA vaccination in pregnant women are transferred to neonates and correlate with breast milk neutralization activity. Nat Med 2021;27(12):2252-2258.
Luisi G, et al. Factors associated with COVID-19 vaccine hesitancy in pregnant women: A systematic review and meta-analysis. Vaccines 2021;9(9):1052.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Women and Child Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Women and Child Health (JoWaCH) adheres to the CC BY 4.0 license, which is a Creative Commons Attribution 4.0 International License. For comprehensive information, we kindly request that you refer to the full license legal code. JoWaCH employs a non-exclusive license agreement for the purpose of open-access publication. In the context of open access publishing, the authors maintain the copyright of their work while also granting the journal the rights to publish and distribute it, while retaining the primary academic use rights. This practice facilitates the optimal use and dissemination of the work, while also guaranteeing proper attribution to the original source. The handling of manuscript content shall be conducted with confidentiality, with the exception of cases involving review processes and investigations related to potential misconduct, plagiarism, and duplicate/redundant or overlapping publications, in accordance with the guidelines provided by the Committee on Publication Ethics (COPE) COPE Guidelines.
JoWaCH is prohibited from disseminating content derived from previously published scientific work without obtaining proper authorization. Obtaining permission from the copyright holder, who may be either the author(s) or the publisher, is necessary in cases where the copyright holder is the publisher, for any work you want to use.
While it is acceptable to use a small amount of a work, obtaining permission from the copyright owners is necessary for a significant extraction.
The use of unmodified or little modified tables, graphs, and artworks (whether they are the user's own work previously published elsewhere or created by another copyright holder) necessitates obtaining permission.
Tables, graphs, charts, and artworks that have been fully redesigned and rebuilt, and include proper reference of the source, do not need obtaining permission.
JoWaCH facilitates unrestricted access to journal material for readers, necessitating the imposition of membership fees. The journal operates on a self-sustaining financial model and does not rely on support from other sources. The procedure of publishing is contingent only upon the financial resources of the publisher. The readers have unrestricted access to the information on the journal website.
